1. 107TiPPhase I safety and pharmacokinetics of ADU-1604, an anti-CTLA-4 antibody, in adults with metastatic melanoma. (17th December 2018) Authors: Hendriks, M; de Cock, E; Maplestone, K; Namini, H; van Elsas, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). (8th October 2018) Authors: Marabelle, A; Andtbacka, R; Harrington, K; Melero, I; Leidner, R; de Baere, T; Robert, C; Ascierto, P A; Baurain, J -F; Imperiale, M; Rahimian, S; Tersago, D; Klumper, E; Hendriks, M; Kumar, R; Stern, M; Öhrling, K; Massacesi, C; Tchakov, I; Tse, A Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗